Germany
University of Leipzig - University Hospital Leipzig
spatial metabolomics, trastuzumab response, metabolic heterogeneity, gastric cancer
precision medicine, Biomarkers, gastric cancer, trastuzumab, HER2, ERBB2, TP53
Gastric cancer, Liver metastases, radiofrequency ablation, systemic therapy, metastasectomy, oligometastases